• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » BioCity Scotland secures former MSD site

BioCity Scotland secures former MSD site

January 18, 2012
CenterWatch Staff

Newly-formed BioCity Scotland, a centralized base for growing bioscience, pharameutical, med tech and health companies, will set up house in the former-MSD research facility at Newhouse, which it acquired Jan. 11.

A joint venture between BioCity Nottingham and Roslin BioCentre, BioCity Scotland will be 15 miles from Glasgow and 33 miles from Edinburgh, a central location for growing companies in Scotland.

The 130,000-square-foot facility consists of purpose-built labs and offices on 23 acres and is capable of supporting pre-clinical drug discovery and development by a range of independent companies. It is equipped with administrative and conference facilities to provide support and networking capabilities for client companies.

BioCity Scotland will provide access to a range of state-of-the-art equipment, available to rent at competitive rates. On-site business support will allow companies to tap into funding opportunities to assist their growing business needs.

“BioCity Scotland is much more than a property proposition—it will be a unique, vibrant community of scientific companies,” said Louis J. Nisbet, chairman of BioCity Scotland. “BioCity Nottingham's success in nurturing and growing over 70 new companies since 2003, and Roslin's expertise in life sciences innovation and facilities management makes this team the perfect commercial partnership."

Upcoming Events

  • 24May

    Powering an Effective Oversight Strategy with Clinical and Operational Insights

  • 25May

    2022 WCG Avoca Quality & Innovation Summit: Own the Future

  • 28Jun

    Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

  • 16Oct

    WCG MAGI's Clinical Research Hybrid Conference - 2022 West

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Protocol-360x240.png

    Avoid Deviations by Making Protocol Review a Team Effort

  • SelectionProcess-360x240.png

    Give Us a Voice: Sites Clamor for a Say on Vendor Selection

  • Convince-360x240.png

    Use Data and Details to Convince Site Leadership to Add Staff

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Listing Trial Staff and Others on the Statement of Investigator

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing